New options for testing and treating some of the most common sexually transmitted diseases are becoming available, a trend ...
The GARDP Foundation (known as GARDP) and the privately-owned, global biopharmaceutical company Debiopharm today announced ...
According to the New York Post, Manteris writes that a Nevada Athletic Commission insider told him Tyson had been taking ...
The GARDP Foundation and Debiopharm have entered a collaboration and license agreement to pursue the development of a novel, first-in-class antibiotic targeting Neisseria gonorrhoeae.
Last year, the US authorities approved the first at-home test that can detect three common infections in women — gonorrhea, ...
Tribune Online on MSN
What everyone should know about gonorrhoea
Gonorrhoea is a common sexually transmitted infection (STI) that affects millions of people worldwide. Many people who have ...
1don MSNOpinion
Legendary bookie dishes on sports ‘fixes’ — like the time gonorrhea knocked Mike Tyson out
In February 1990, world heavyweight champion Mike Tyson, boasting a record of 37 wins and no defeats, faced up against James ...
Debio1453 is a first-in-class antibiotic candidate that targets an enzyme that’s essential for the growth of Neisseria ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback